cleoy6v2y
Dołączył: 10 Sie 2013
Posty: 13066
Przeczytał: 0 tematów
Ostrzeżeń: 0/5 Skąd: England
|
Wysłany: Sob 23:52, 31 Sie 2013 Temat postu: abercrombie milano GlaxoSmithKline Whistleblower |
|
|
GlaxoSmithKline Whistleblower: False-Claims Lawsuit Involving Popular Prescription drugs Including Avandia and Paxil
Three [link widoczny dla zalogowanych] months ago, pharmaceutical maker GlaxoSmithKline agreed to compensate $750 million to resolve a U.S. government false-claims lawsuit over charges that the organization knowingly built and sold adulterated prescription drugs. The affected prescription drugs involved in the suit included the heavily prescribed antidepressant, Paxil and Avandia, a medication taken for type II diabetes.
This week, the whistleblower accountable for bringing to light the issues a Glaxo plant has, that resulted in the false-claims lawsuit, spoke out for [link widoczny dla zalogowanych] the very first time on 60 minutes. In her interview, the former Glaxo global quality assurance manager, Cheryl Eckard, made public the shocking disregard shown by the company for the safety and quality of the products they manufacture.
Cheryl Eckard first learned of issues when she was sent to [link widoczny dla zalogowanych] evaluate a Glaxo factory in Cidra, Puerto Rico and observed numerous production problems causing some drugs to become tainted, mislabeled, or incorrectly dosed. Eckard told 60 Minutes reporter Scott Pelley "All the systems were in poor condition, the facility was broken, the equipment was broken, the processes were in poor condition. It was the worst thing I had run across in my career.â
Eckard alleges that after eight months of reporting [link widoczny dla zalogowanych] these issues with out company response, she designed a chart for Glaxo executives showing nine problem areas at the Cidra plant. The chart involved allegations that production problems at the plant were causing strong medicines to be mixed jointly in the same bottles.
In accordance with Eckard, her claims continued to be dismissed; and after a pharmacist [link widoczny dla zalogowanych] reported a mix-up involving incorrectly labeled Paxil prescribed to an 8-year-old boy, the drug company filed a report [link widoczny dla zalogowanych] with the [link widoczny dla zalogowanych] FDA declaring it was extremely unlikely that the drug mix-up took place at Cidra. Cheryl Eckard was let go shortly after her letter to company executives detailing problems [link widoczny dla zalogowanych] at Cidra. After Eckard was fired, she brought her complaints to the FDA.
In 2005, Cidra was raided and Federal investigators mentioned that the state of affairs found at the Glaxo factory were far from meeting public health standards. Cidra was shut down in 2009 and is no longer owned by GlaxoSmithKline.
Under the federal False Claims Act, whistleblowers like Eckard may be entitled to receive a portion of any money that the government recovers from the offenders. In order to receive a portion of the recovered money, the whistleblower must be the first to bring the case to [link widoczny dla zalogowanych] the governmentâs attention, and must not publicize the claim until the DOJ decides to prosecute the claim. Cheryl Eckard received a record $96 million from the settlement.
Whistleblower Lawsuits on the Rise
Based on consumer watchdog group Public Citizen, the pharmaceutical industry has surpassed the protection sector to grow to be the leading defrauder of the federal government. There have been 165 pharmaceutical industry settlements with the federal government over fraud charges in the previous 20 years and drug companies have paid out a total of $19.8 billion in Settlements; 73% of those cases, and 75% of that capital, have transpired in just the last 5 years. This boost in payments for fraud is likely due to both an increase in wrongdoing on the part of drug companies [link widoczny dla zalogowanych] and better enforcement by the state and federal government. More than half of the pharmaceutical industryâs penalties have been paid by just four companies: GlaxoSmithKline, Pfizer, Eli Lilly and Schering-Plough.
A public citizen report showed that from 1991 to 2000, whistleblower lawsuits accounted for only 9% of federal fraud settlements, however, from 2001 through 2010, they accounted for 67%. Whistleblowers like Cheryl Eckerd are one of the only ways for the government, and the public, to find out about potentially disastrous problems like those at GlaxoSmithKline, that threaten the safety of widely prescribed drugs like Paxil and Avandia. Patient advocates hope that Cheryl Eckerd making her story public, [link widoczny dla zalogowanych] as well as her generous reward, will encourage others to hold these pharmaceutical giants to [link widoczny dla zalogowanych] the huge responsibilities they undertake when manufacturing medicines for the nation.
Avandia Lawsuits have been filed by many plaintiffs that suffered a variety of side effects of Avandia. Each Avandia Lawsuitsfiled has added to the final settlement amount that GSK is likely to pay out to resolve suits that continue to be filed by Avandia [link widoczny dla zalogowanych] Lawyers at Parliman and Associates.
Most Paxil Lawsuits have been ,Paxil Birth Defect Lawsuits. Every Paxil Birth Defect Lawsuit filed also adds to the [link widoczny dla zalogowanych] future amount GSK will ultimately pay out to resolve all of thePaxil Birth Defect Lawsuits it now faces. Numerous Paxil Lawyers, as they are often referred to by the public, expect to file future lawsuits on behalf of clients [link widoczny dla zalogowanych] that have given birth to an infant with Paxil Birth Defect Lawsuits. Parliman and Associates plans to represent clients Paxil Birth Defect Lawsuits as long as the issue of Paxil Birth Defect Lawsuitscontinues to exist.
Post został pochwalony 0 razy
|
|